Examen et analyse du paysage des données sur les médicaments pharmaceutiques au Canada et conseils pour soutenir l'élaboration d'une stratégie nationale en matière de données sur les médicaments

The Canadian Drug Agency Transition Office requires one (1) Senior Level Business Consultant to provide expert analysis with respect to developing a data strategy for the pharmaceutical management system. The analysis will include three distinct phases of work: Phase 1 – Review of the Drug Data Landscape, Phase 2 – Analysis of Barriers, Strengths and Opportunities for improving access to Drug Data and Phase 3 – Advice on getting started and the Canadian Drug Agency’s role. The Business Consultant will be required over a period of approximately 14 weeks.